Clinical Trial Update: Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating mesenchymal stem cells enriched with extracellular vesicles for treating bone defects from segmental fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Segmental Fracture - Bone Loss

Drugs mentioned

• mesenchymal stem cells enriched by extracellular vesicles

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Segmental Fracture - Bone Loss | Phase 1, Phase 2 | Status: UNKNOWN